Phase I/II study of sorefenib and erlotinib for patients with recurrent glioblastoma (GBM) (NABTC 05-02) Meeting Abstract
| Authors: | Prados, M.; Gilbert, M.; Kuhn, J.; Lamborn, K.; Cloughesy, T.; Lieberman, F.; Puduvalli, V.; Robins, H. I.; Lassman, A.; Wen, P. Y. |
| Abstract Title: | Phase I/II study of sorefenib and erlotinib for patients with recurrent glioblastoma (GBM) (NABTC 05-02) |
| Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2009 May 29-Jun 2 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-05-20 |
| Start Page: | 88s |
| Language: | English |
| ACCESSION: | WOS:000276606602153 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2009.27.15_suppl.2005 |
| Notes: | Meeting Abstract: 2005 -- Source: Wos |
